These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 11003667)
1. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667 [TBL] [Abstract][Full Text] [Related]
2. Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport. Camacho-Carvajal MM; Klingler S; Schnappauf F; Hake SB; Steimle V Int Immunol; 2004 Jan; 16(1):65-75. PubMed ID: 14688062 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Zika E; Greer SF; Zhu XS; Ting JP Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811 [TBL] [Abstract][Full Text] [Related]
4. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex. Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990 [TBL] [Abstract][Full Text] [Related]
5. Leucine-rich repeats of the class II transactivator control its rate of nuclear accumulation. Harton JA; O'Connor W; Conti BJ; Linhoff MW; Ting JP Hum Immunol; 2002 Jul; 63(7):588-601. PubMed ID: 12072194 [TBL] [Abstract][Full Text] [Related]
6. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation. Masternak K; Reith W EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043 [TBL] [Abstract][Full Text] [Related]
7. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes. Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658 [TBL] [Abstract][Full Text] [Related]
8. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Zhu XS; Linhoff MW; Li G; Chin KC; Maity SN; Ting JP Mol Cell Biol; 2000 Aug; 20(16):6051-61. PubMed ID: 10913187 [TBL] [Abstract][Full Text] [Related]
10. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study. Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641 [TBL] [Abstract][Full Text] [Related]
11. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III. Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568 [TBL] [Abstract][Full Text] [Related]
12. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of class II transactivator regulates its interaction ability and transactivation function. Sisk TJ; Nickerson K; Kwok RP; Chang CH Int Immunol; 2003 Oct; 15(10):1195-205. PubMed ID: 13679389 [TBL] [Abstract][Full Text] [Related]
14. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. Brown JA; Rogers EM; Boss JM Nucleic Acids Res; 1998 Sep; 26(18):4128-36. PubMed ID: 9722631 [TBL] [Abstract][Full Text] [Related]
15. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene. Peijnenburg A; Van den Berg R; Van Eggermond MJ; Sanal O; Vossen JM; Lennon AM; Alcaïde-Loridan C; Van den Elsen PJ Immunogenetics; 2000 Jan; 51(1):42-9. PubMed ID: 10663561 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator. Cressman DE; O'Connor WJ; Greer SF; Zhu XS; Ting JP J Immunol; 2001 Oct; 167(7):3626-34. PubMed ID: 11564775 [TBL] [Abstract][Full Text] [Related]
17. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module. Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463 [TBL] [Abstract][Full Text] [Related]
18. Self-association of CIITA and its transactivation potential. Sisk TJ; Roys S; Chang CH Mol Cell Biol; 2001 Aug; 21(15):4919-28. PubMed ID: 11438649 [TBL] [Abstract][Full Text] [Related]
19. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes. Lochamy J; Rogers EM; Boss JM Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065 [TBL] [Abstract][Full Text] [Related]
20. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA. Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]